For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on June 3rd, 2025 | 07:20 CEST
A bombshell and a buying opportunity! BioNTech, Bayer, and AI stock NetraMark
Bombshell news from BioNTech. The Company has announced a collaboration for its cancer pipeline - billions in revenue are on the horizon. The stock has surged significantly. Are there other exciting buying opportunities in the biotech and pharma sectors right now? US politics have recently dampened industry sentiment. The Trump administration wants to lower drug prices. One potential beneficiary is NetraMark, as this AI gem helps industry cut development costs and timelines. In addition, takeover speculation could drive the stock in the second half of the year. And what is Bayer doing? The stock has outperformed the DAX in 2025. Are there reasons to consider buying?
Read
Commented by Fabian Lorenz on June 3rd, 2025 | 07:10 CEST
SHOCK for RENK, "BUY" rating for Novo Nordisk, and PanGenomic Health follows in the footsteps of Hims & Hers
Shock for RENK & Co.! Yesterday afternoon, news broke that the EU plans to tap into the billions in profits made by defense companies. After all, these companies are facing a golden age. The shares ended their record run yesterday. The alternative medicine and dietary supplements sector is currently experiencing a boom in the US. PanGenomic Health wants a piece of that multi-billion-dollar market. The newcomer is launching an AI-based app offering recommendations, a marketplace, and diagnostics. The rollout will begin this summer. Anyone who missed out on the 800% gains at Hims & Hers should take a look at this newcomer. Novo Nordisk is a core investment in the pharmaceutical sector. However, expectations for the blockbuster drug Ozempic were likely set too high. After the stock's crash, things are now looking better again.
Read
Commented by Fabian Lorenz on June 2nd, 2025 | 07:15 CEST
Alarm bells ringing for rare earths and record highs for hydrogen! Hensoldt, Plug Power, Mercedes, and BMW partner European Lithium
Rare earths are increasingly being used as a weapon in geopolitics. "The last remaining stocks will likely be used up within four to six weeks. Then parts of production will have to be shut down," warns Christian Grimmelt of the consulting firm Berylls by AlixPartners in Wirtschaftswoche. This could benefit European Lithium's stock. The Company not only aims to supply lithium to BMW but is also developing a rare earths project in Greenland. Is the defense industry also affected by the shortage of raw materials? Perhaps. For now, the FOMO rally is driving defense stocks to new all-time highs. But caution is advised: according to analysts, Hensoldt shares, for example, have a 30% downside risk. Plug Power, on the other hand, has had to cope with many setbacks in recent months. Its shares are at rock bottom. Could a milestone in its home market bring about a turnaround?
Read
Commented by Fabian Lorenz on May 30th, 2025 | 07:00 CEST
D-Wave shares with insider alert! Nel and Samsung step on the gas! Walmart partner MiMedia makes a big splash!
Insider alert at D-Wave Quantum. Numerous executives have sold shares in recent weeks, taking advantage of the quantum highflyer's record levels to take profits. Should investors do the same? There was positive news at MiMedia. On Wednesday, the cloud hidden gem announced a new partnership with a smartphone manufacturer. Is the stock now heading for a new all-time high? In any case, the valuation appears attractive. At Nel, new major shareholder Samsung is increasingly taking the reins. In addition to the change in the board of directors, a joint product was presented. Will the struggling hydrogen play manage a turnaround?
Read
Commented by Fabian Lorenz on May 29th, 2025 | 07:10 CEST
Rheinmetall unstoppable! Evotec shorted! Sensational news at Vidac Pharma! And what is BioNTech doing?
Sensational news at Vidac Pharma. Last year's biotech highflyer has published strong results for its cancer drug. The share price rose by 5% yesterday. Does this mean the consolidation is over? Analysts certainly see potential for a multiplication in value. Rheinmetall shares have gained over 200% this year alone. Analysts are raising their price targets and continue to recommend buying. Operationally, a lot is happening at the defense company. Meanwhile, Evotec has run out of steam operationally. The stock has become a plaything for takeover speculators and short sellers — who will win? BioNTech also wants to win the fight against cancer. Will the stock gain new momentum in the coming days?
Read
Commented by Fabian Lorenz on May 28th, 2025 | 07:05 CEST
OUT of defense, INTO crypto and quantum? RENK, Bitcoin Group, Strategy, and Credissential!
Defense stocks are unstoppable! RENK and Rheinmetall, among others, hit new all-time highs yesterday, with the entire defense sector on fire. The charts have already formed flagpole patterns. Crypto and quantum are also hot, but unlike defense, they are scalable. Credissential is one example of this. The tech company is currently still flying under the radar of most investors. However, with crypto, quantum, and AI, it aims to scale up in payment services and online car trading. If this succeeds during the current year, the stock could be a real bargain. Strategy – formerly Microstrategy – is valued higher than its own Bitcoin holdings, but investors seem to believe that CEO and industry star Michael Saylor can deliver outperformance. However, the Company is now facing a lawsuit. And what is the Bitcoin Group doing? The stock has jumped and forecasts have been exceeded, but...
Read
Commented by Fabian Lorenz on May 27th, 2025 | 07:10 CEST
Between bankruptcy and multiplication: Cleantech stocks Siemens Energy, Plug Power, and dynaCERT
More losses than revenue is never a good sign for any business model. Given the muted reactions to the quarterly figures, Plug Power investors seem to have grown accustomed to this pattern. Despite planned cost reductions, a return to profitability is not yet in sight. Still, a company executive has made a symbolic move, suggesting internal confidence. According to analysts, dynaCERT could make the leap into the black as early as next year. On this basis, the cleantech company is currently attractively valued, and experts consider a multiplication of its share price possible. Siemens Energy has shown how quickly a stock can shoot into a new dimension. Almost bankrupt 1.5 years ago, it is now one of the stars of the DAX and is receiving praise even from otherwise critical corners.
Read
Commented by Fabian Lorenz on May 26th, 2025 | 07:00 CEST
RENK, D-Wave, and drone insider tip Volatus Aerospace: INSIDER SALE, SHARE PRICE EXPLOSION, 100% OPPORTUNITY
Another drone insider tip is Volatus Aerospace. There is growth potential in civil and military applications. The Company earns money, among other things, by training drone pilots and monitoring areas and bridges. Analysts expect strong sales and profit growth in the coming years and conservatively estimate that the stock could rise by more than 100%. Is it time to take profits at RENK? In any case, one insider has cashed in. This is understandable, given that the defense stock has already gained around 270% this year alone. And the quantum hype is back. Following a "milestone for the industry," D-Wave shares exploded by 50% in one week.
Read
Commented by Fabian Lorenz on May 22nd, 2025 | 07:00 CEST
Another 100% with momentum stocks Rheinmetall, TUI, and 123fahrschule?! Analysts recommend buying
Are Rheinmetall's forecasts too conservative? One analyst thinks so. If this is true, there is a good chance that the defense company's shares will break through the EUR 2,000 mark. The 123fahrschule share is also riding a wave of momentum, rising by around 70% within just a few weeks. This could be just the beginning, as the Company is disrupting an analog industry with a digital business model. Analysts believe a further 100% price gain is possible, and the management board wants to buy shares well above the current price. In contrast, darker clouds are gathering at TUI. The tourism group has long been able to withstand the weak economy, but is that now over? The price targets vary widely.
Read
Commented by Fabian Lorenz on May 21st, 2025 | 07:00 CEST
Stocks on the verge of MULTIPLYING? BioNTech, D-Wave, and hot stock Argo Living Soils aim to revolutionize their markets! Buy now?
These companies want to turn billion-dollar markets upside down: Argo Living Soils, BioNTech, and D-Wave. Argo Living Soils aims to revolutionize infrastructure construction through nanotechnology. Concrete and asphalt are to become more durable and environmentally friendly through nanotechnology. This could, for example, make buildings and bridges better protected against earthquakes. The potential is enormous, and the hot stock is valued at less than CAD 10 million, offering the chance for a multiple increase. D-Wave has impressively demonstrated how quickly a revaluation can take place. Quantum computing has the potential to change the world. But big players like Alphabet, NVIDIA, and others also want a big piece of the pie. At BioNTech, the focus remains on the fight against cancer. The stock appears to have halted its sell-off, but analysts are lowering their price targets. Where is the right entry point now?
Read